Technical report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis
World Health Organization. (2018). Technical report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis. World Health Organization. http://www.who.int/iris/handle/10665/260470. License: CC BY-NC-SA 3.0 IGO
Gov't Doc #WHO/CDS/TB/2018.5
MetadataShow full item record
Showing items related by title and MeSH subject.
Joint TDR/EC expert consultation on biomarkers in tuberculosis : report of the joint TDR/EC expert consultation to evaluate the potential roles of biomarkers in the management of HIV-infected and HIV-uninfected patients with tuberculosis, Geneva, Switzerland, 2-3 July 2008 / Alimuddin Zumla [...et al.] Zumla, Alimuddin; Wallis, Robert; Klein, Nigel; Oleson, Ole; Lang, Hannu; Vahedi, Mahnaz; Onyebujoh, Philip; UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (2009)
Using the Xpert MTB/RIF assay to detect pulmonary and extrapulmonary tuberculosis and rifampicin resistance in adults and children : expert group meeting report : 2013 World Health Organization (WHO/HTM/TB/2013.14, 2013)